Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalie E Parks

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Multiple Sclerosis and Related Disorders|January 19, 2024
Predicting time to serologic diagnosis of AQP4+ NMOSD based on clinical factors and social determinants of healthDalia L Rotstein, Mark S Freedman, Liesly Lee, et al.
Acta Neuropathologica|February 11, 2017
Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis opticaYong Guo, Stephen D Weigand, Bogdan F Popescu, et al.
Multiple Sclerosis and Related Disorders|March 29, 2025
Comparison of vision-related quality of life in NMOSD and MOGADAdnan A Gassan, Andrea Konig, Rosane Nisenbaum, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 14, 2018
Population-based study of "no evident disease activity" in MSNatalie E Parks, Sean J Pittock, Jay Mandrekar, et al.
Multiple Sclerosis and Related Disorders|May 12, 2026
Patient reported outcomes in NMOSD reflect a high disease burden and do not correlate with the EDSSElisa Saeedzadeh, Manav V Vyas, Shristi Sharma, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Multiple Sclerosis and Related Disorders|January 19, 2024
Predicting time to serologic diagnosis of AQP4+ NMOSD based on clinical factors and social determinants of healthDalia L Rotstein, Mark S Freedman, Liesly Lee, et al.
Acta Neuropathologica|February 11, 2017
Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis opticaYong Guo, Stephen D Weigand, Bogdan F Popescu, et al.
Multiple Sclerosis and Related Disorders|March 29, 2025
Comparison of vision-related quality of life in NMOSD and MOGADAdnan A Gassan, Andrea Konig, Rosane Nisenbaum, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 14, 2018
Population-based study of "no evident disease activity" in MSNatalie E Parks, Sean J Pittock, Jay Mandrekar, et al.
Multiple Sclerosis and Related Disorders|May 12, 2026
Patient reported outcomes in NMOSD reflect a high disease burden and do not correlate with the EDSSElisa Saeedzadeh, Manav V Vyas, Shristi Sharma, et al.
Pageof 2